Table 5.
Hazard rates from Gompertz survival analysis models, with cause-specific mortality during current year as the dependent variable
| Men | Women | Men | Women | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure Period | Model 5 Cancer |
Model 6 Cardiovascular Disease |
Model 7 Respiratory Disease |
Model 8 Other |
Model 9 Cancer |
Model 10 Cardiovascular Disease |
Model 11 Respiratory Disease |
Model 12 Other |
Model 13 Cancer |
Model 14 Cardiovascular Disease |
Model 15 Respiratory Disease |
Model 16 Other |
Model 17 Cancer |
Model 18 Cardiovascular Disease |
Model 19 Respiratory Disease |
Model 20 Other |
| 49–60 Months After Birth | 0.979 | 1.017 | 0.823* | 0.910 | 0.957 | 1.016 | 1.048 | 0.940 | ||||||||
| 37–48 Months After Birth | 0.990 | 1.035† | 0.957 | 0.989 | 0.989 | 0.997 | 1.014 | 1.016 | ||||||||
| 25–36 Months After Birth | 0.990 | 1.004 | 1.067 | 0.988 | 1.046 | 1.048* | 0.911† | 1.039 | ||||||||
| 19–24 Months After Birth | 0.991 | 1.017 | 0.994 | 0.981 | 1.056* | 0.996 | 0.954 | 0.963 | ||||||||
| 13–18 Months After Birth | 0.965 | 1.013 | 1.011 | 1.033 | 1.069* | 1.019 | 0.947 | 1.035 | ||||||||
| 7–12 Months After Birth | 0.982 | 1.006 | 0.985 | 1.028 | 1.007 | 1.025 | 1.041 | 0.964 | ||||||||
| 0–6 Months After Birth | 1.025 | 0.996 | 1.036 | 1.019 | 1.030 | 1.005 | 0.967 | 0.960 | ||||||||
| Third Trimester | 0.966 | 0.986 | 1.030 | 1.019 | 1.007 | 1.023 | 1.027 | 0.975 | 0.945* | 0.994 | 1.005 | 1.025 | 1.006 | 1.041† | 1.044 | 0.974 |
| Second Trimester | 1.088** | 1.034† | 0.957 | 0.895* | 0.993 | 1.013 | 0.979 | 0.996 | 1.068† | 1.031 | 0.920 | 0.894† | 0.994 | 1.013 | 0.985 | 1.000 |
| First Trimester | 0.983 | 0.962* | 1.011 | 0.976 | 0.994 | 1.004 | 0.994 | 0.997 | 0.984 | 0.958* | 1.017 | 0.988 | 0.997 | 1.004 | 1.003 | 0.991 |
| 0–6 Months Before Conception | 0.966 | 1.002 | 0.952 | 1.000 | 1.008 | 1.019 | 0.993 | 1.004 | ||||||||
| 7–12 Months Before Conception | 1.060† | 0.994 | 1.021 | 1.142* | 1.042 | 0.970 | 1.010 | 1.015 | ||||||||
| 13–18 Months Before Conception | 0.996 | 1.000 | 0.974 | 1.087* | 0.999 | 1.013 | 0.994 | 1.003 | ||||||||
| 19–24 Months Before Conception | 0.961 | 0.950* | 0.972 | 1.002 | 0.974 | 0.958† | 1.138* | 1.001 | ||||||||
| 25–36 Months Before Conception | 1.000 | 0.977 | 1.048 | 1.009 | 0.971 | 0.995 | 1.021 | 0.976 | ||||||||
| 37–48 Months Before Conception | 0.970 | 0.978 | 1.036 | 0.982 | 1.011 | 1.006 | 0.983 | 0.997 | ||||||||
| 49–60 Months Before Conception | 0.985 | 0.980 | 0.959 | 0.976 | 1.022 | 1.023 | 0.921 | 1.026 | ||||||||
| 61–72 Months Before Conception | ||||||||||||||||
| Number of Observations | 442,521 | 442,521 | 442,521 | 442,521 | 471,547 | 471,547 | 471,547 | 471,547 | 442,521 | 442,521 | 442,521 | 442,521 | 471,547 | 471,547 | 471,547 | 471,547 |
†p < .10; *p < .05; **p < .01